Genetically engineered rapamycin responsive K2P channels
Leila Khajoueinejad, Elena B. Riel, Aben Ovung, Aboubacar Wague, Caroline Malkin, Syed S Islam, Karl F. Herold, Hugh C. Hemmings, Em B Sorum, Rie Nygaard, Paul M. Riegelhaupt
This paper genetically engineers K2P channels to be activated by rapamycin or its analogs, enabling chemogenetic control of cellular membrane potential.
bioRxiv · May 26, 2026 · PreprintBioengineering